M&A Transactionβ€’

HIG Capital Acquires Pharmacy Tech Firm Outcomes

HIG Capital invests in Outcomes One, a key player in pharmacy technology and clinical network services, aiming to enhance patient care and operational efficiency.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Healthcare, Healthtech & Medtech, Technology, Software & Gaming in United States" are published.

Key Takeaways

  • H.I.G. Capital acquired Outcomes One.
  • Sector: Healthcare, Healthtech & Medtech, Technology, Software & Gaming.
  • Geography: United States.

Analysis

H.I.G. Capital, a prominent global alternative investment firm managing $75 billion in capital, has finalized its acquisition of Outcomes One, a significant player in clinical network services and pharmacy technology. This strategic move by H.I.G. Capital underscores the growing investor interest in healthcare technology solutions that demonstrably enhance patient care and operational efficiency within the pharmacy sector.

Outcomes, based in Orlando, Florida, operates a comprehensive national network that connects approximately 85% of U.S. pharmacies. The company's core mission revolves around empowering pharmacists to deliver crucial clinical interventions and medication-based care, thereby improving patient health outcomes. In 2025 alone, the company facilitated over 10 million such interventions, impacting the lives of 130 million individuals. This extensive reach positions Outcomes as a vital intermediary in the healthcare ecosystem, bridging the gap between pharmacies, health plans, pharmaceutical manufacturers, and data providers.

Beyond its robust clinical network, Outcomes offers an integrated technology suite designed to streamline pharmacy operations. This includes advanced pharmacy management software and workflow automation tools that support essential daily functions such as prescription processing, dispensing, billing, and inventory management. The company's solutions cater to a diverse clientele, ranging from national and regional pharmacy chains to health systems, specialty pharmacies, long-term care facilities, and independent community pharmacies, highlighting the broad applicability and essential nature of its offerings.

The acquisition is expected to fuel further innovation and expansion for Outcomes. Jude Dieterman, CEO of Outcomes, expressed enthusiasm for the partnership, stating, "Our collaboration with H.I.G. will provide us with enhanced resources and expertise to continue investing in our unique pharmacist-led clinical network and leading technology platforms like Rx30, Computer-Rx, and Outcomes Premium. This will enable us to deliver even greater value to our pharmacy partners, health plans, pharmaceutical manufacturers, and ultimately, patients."

Arjun Mohan, Managing Director at H.I.G. Capital, emphasized the strategic alignment, noting, "Outcomes has developed a distinctive technology platform that underpins critical health services proven to elevate patient results. We are eager to support the Outcomes team in their commitment to delivering superior technology, services, and innovation, while simultaneously advancing the pivotal role of pharmacies within the broader healthcare system." The healthcare technology market, particularly solutions focused on value-based care and medication management, has seen substantial growth, with projections indicating continued expansion driven by an aging population and increasing demand for accessible, efficient healthcare services.

This transaction represents a significant development in the healthtech sector, where companies are increasingly leveraging technology to improve patient engagement, medication adherence, and overall health management. The integration of clinical services with advanced pharmacy management software offers a compelling model for value creation, aligning with the industry's shift towards more patient-centric and outcome-driven care. H.I.G. Capital's investment is poised to accelerate Outcomes' growth trajectory, potentially setting new benchmarks for pharmacy-enabled healthcare services.